+3,738.7%
PANW vs GSK
+112.3%
+3,626.5%
-48.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +9.9% | -1.3% | +11.2% | +10.3% |
| 7D | +1.6% | -3.1% | +4.8% | +2.4% |
| 30D | -2.0% | -0.9% | -1.1% | -1.9% |
| 3M | -9.1% | -4.2% | -5.0% | -8.4% |
| 6M | +37.3% | -1.6% | +38.9% | +36.8% |
| YTD | +84.5% | +2.6% | +81.9% | +79.3% |
| 1Y | +69.1% | +6.2% | +62.9% | +62.4% |
| 3Y | +174.6% | +55.0% | +119.6% | +125.1% |
| 5Y | +292.2% | +42.8% | +249.4% | +225.7% |
| 10Y | +1,164.0% | +102.1% | +1,061.9% | +756.1% |
| All | +3,738.7% | +112.3% | +3,626.5% | +2,622.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling